GlassScriptPhysician profile
Xiaorong He
NPI 1962422972
$12,520.61
in general payments reported to CMS, 2019-2025
16 companies · $1,754 in 2025
The $1,754 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,214 · 2020: $1,059 · 2021: $2,434 · 2022: $2,148 · 2023: $1,954 · 2024: $1,959 · 2025: $1,754.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,657 · Education: $10.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,656.62 |
| Education | $10.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,625.04 | 2019-2025 | |
| Gilead Sciences, INC. | $3,292.56 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,227.93 | 2020-2025 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $1,060.35 | 2019-2025 | Evenity, Prolia, Otezla |
| Janssen Pharmaceuticals, INC | $825.22 | 2019-2022 | |
| Amarin Pharma, INC. | $818.12 | 2020-2023 | |
| Horizon Therapeutics Plc | $781.83 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $368.12 | 2019-2025 | Zoryve |
| Insmed, INC. | $220.92 | 2019 | |
| Genzyme Corporation | $119.87 | 2024 | |
| Glaxosmithkline, LLC. | $52.58 | 2025 | Arexvy, Shingrix |
| Novartis Pharmaceuticals Corporation | $40.05 | 2023 | |
| Lilly USA, LLC | $25.84 | 2024 | Jardiance |
| Ironwood Pharmaceuticals, INC | $20.98 | 2021 | |
| Allergan, INC. | $20.90 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.30 | 2024 | Trulance, Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xiaorong He listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.